BUSINESS: Intensity Therapeutics Reports Promising Overall Survivability Results Using INT230-6 In Monotherapy Or In Combination With Pembrolizumab Or Ipilimumab To Treat Solid Tumors At The Society For Immunotherapy Of Cancer’s 36th Annual Meeting
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Intensity Therapeutics Reports Promising Overall Survivability Results Using INT230-6 In Monotherapy Or In Combination With Pembrolizumab Or Ipilimumab To Treat Solid Tumors At The Society For Immunotherapy Of Cancer’s 36th Annual Meeting

WESTPORT, Conn., Nov. 13, 2021 /PRNewswire/ — Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company focused on the discovery and development of proprietary immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced the Company made two presentations on novel lead asset, INT230-6, at the Society for Immunotherapy…

BUSINESS: BMY EAR, HMLP SHAREHOLDERS – ALERT BY FORMER LOUISIANA ATORNEY GENERAL Class Action Lawsuits Filed For Investors, Lead Plaintiff Deadlines Set
| | | | | | | | | | | | | |

BUSINESS: BMY EAR, HMLP SHAREHOLDERS – ALERT BY FORMER LOUISIANA ATORNEY GENERAL Class Action Lawsuits Filed For Investors, Lead Plaintiff Deadlines Set

NEW ORLEANS, Nov. 12, 2021 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares…

FRONT PAGE: Combining Two ‘Old Therapies’ Packs A Powerful Punch Against Pediatric Brain Tumors
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

FRONT PAGE: Combining Two ‘Old Therapies’ Packs A Powerful Punch Against Pediatric Brain Tumors

Newswise — Copper has been clinically improving the lives of people since about 1500 BCE, when an Egyptian physician first recorded its use as a treatment for inflammation. Some 35 centuries later, researchers at Johns Hopkins Medicine and Italy’s Catholic University of the Sacred Heart medical school have provided solid evidence that the first metal…

BUSINESS: SHAREHOLDER ALERTED BY FORMER LOUISIANA ATTTORNEY GENERAL KSF REMINDS BMY.EAR.HYZN.WDH INVESTORS Of The Lead Plaintiff Deadline For Class Action Lawsuits
| | | | | | | | | | | | | |

BUSINESS: SHAREHOLDER ALERTED BY FORMER LOUISIANA ATTTORNEY GENERAL KSF REMINDS BMY.EAR.HYZN.WDH INVESTORS Of The Lead Plaintiff Deadline For Class Action Lawsuits

NEW ORLEANS, Oct. 29, 2021 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Waterdrop Inc. (WDH)Class Period: purchase of shares issued either in or after the May 2021 Initial Public…

BUSINESS: SHAREHOLDER ALERTED BY FORMER LOUISIANA ATTTORNEY GENERAL KSF REMINDS APPH. BMY. EAR. HYZN INVESTORS Of The Lead Plaintiff Deadline For Class Action Lawsuits
| | | | | | | | | | | | | | |

BUSINESS: SHAREHOLDER ALERTED BY FORMER LOUISIANA ATTTORNEY GENERAL KSF REMINDS APPH. BMY. EAR. HYZN INVESTORS Of The Lead Plaintiff Deadline For Class Action Lawsuits

NEW ORLEANS, Oct. 25, 2021 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: AppHarvest, Inc. (APPH)Class Period: 5/17/2021 – 8/10/2021 Lead Plaintiff Motion Deadline: November 23, 2021SECURITIES FRAUD To learn…

BUSINESS: BMY, HNST, HYZN, SAM INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline In Class Action Lawsuits
| | | | | | | | | | |

BUSINESS: BMY, HNST, HYZN, SAM INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline In Class Action Lawsuits

NEW ORLEANS, Oct. 22, 2021 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: The Boston Beer Company, Inc. (SAM)Class Period: 4/22/2021 – 9/8/2021 Lead Plaintiff Motion Deadline: November 15, 2021SECURITIES FRAUD To learn more, visit https://claimsfiler.com/cases/nyse-sam/   The Honest Company, Inc. (HNST)Class Period:…

BUSINESS: APPH BMY, EAR HYZN SHAREHOLDERS – ALERT BY FORMER LOUISIANA ATORNEY GENERAL Class Action Lawsuits Filed For Investors, Lead Plaintiff Deadlines
| | | | | | | | | | | | | | |

BUSINESS: APPH BMY, EAR HYZN SHAREHOLDERS – ALERT BY FORMER LOUISIANA ATORNEY GENERAL Class Action Lawsuits Filed For Investors, Lead Plaintiff Deadlines

NEW ORLEANS, Oct. 15, 2021 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: AppHarvest, Inc. (APPH)Class Period: 5/17/2021 – 8/10/2021 Lead Plaintiff Motion Deadline: November 23, 2021SECURITIES FRAUD To learn…

| | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: FRMO Corp. Appoints Three New Directors

WHITE PLAINS, N.Y.–(BUSINESS WIRE)–FRMO Corp. (the “Company” or “FRMO”) (OTC Pink: FRMO) today announced that it has expanded the size of the Board of Directors and has appointed Alice C. Brennan, Herbert M. Chain, and Dov Glickman to the Board. With the appointment of Ms. Brennan, Mr. Chain, and Mr. Glickman, FRMO Corp. has nine…

BUSINESS: Targeted Therapeutics Market
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Targeted Therapeutics Market

New York, Oct. 11, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Targeted Therapeutics Market” – https://www.reportlinker.com/p06173683/?utm_source=GNWBased on application, targeted therapeutics is divided into lung cancer, breast cancer, blood cancer, colorectal cancer and others.By geography, the market has been divided into four regions: North America, Europe, Asia-Pacific and the Rest of the…

BUSINESS: SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HYZN, INVESTORS Of Lead Plaintiff Deadline In Class Action Lawsuits
| | | | | | | | | |

BUSINESS: SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HYZN, INVESTORS Of Lead Plaintiff Deadline In Class Action Lawsuits

NEW ORLEANS, Oct. 08, 2021 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: AppHarvest, Inc. (APPH)Class Period: 5/17/2021 – 8/10/2021 Lead Plaintiff Motion Deadline: November 23, 2021SECURITIES FRAUD To learn more, visit https://claimsfiler.com/cases/nasdaq-apph/ Hyzon Motors Inc. (HYZN, HYZNW) f/k/a Decarbonization Plus Acquisition…

BUSINESS: Global Anti-Infective Drugs Market To Recover By 2025 To Reach $158.29 Billion
| | | | | |

BUSINESS: Global Anti-Infective Drugs Market To Recover By 2025 To Reach $158.29 Billion

Dublin, Sept. 23, 2021 (GLOBE NEWSWIRE) — The “Anti-Infective Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030” report has been added to ResearchAndMarkets.com’s offering. Anti-Infective Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists,…

BUSINESS: Psoriatic Arthritis Treatment Market To Surpass US$ 17,765.0 Million By 2028, Says Coherent Market Insights (CMI)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

BUSINESS: Psoriatic Arthritis Treatment Market To Surpass US$ 17,765.0 Million By 2028, Says Coherent Market Insights (CMI)

SEATTLE, Sept. 14, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global psoriatic arthritis treatment market is estimated to be valued at US$ 10,100.9 million in 2021 and is expected to exhibit a CAGR of 8.4% over the forecast period (2021-2028). Key Trends and Analysis of the Global Psoriatic Arthritis Treatment Market: Key…

RESEARCH: Ludwig Lausanne Researchers Show a Little Radiation Goes a Long Way in Heating Up Cold Tumors
| | | | | | | | | | | | | | | | | | | | | | |

RESEARCH: Ludwig Lausanne Researchers Show a Little Radiation Goes a Long Way in Heating Up Cold Tumors

Newswise — SEPTEMBER 09, 2021, NEW YORK – A Ludwig Cancer Research study conducted in both mice and a small group of patients with advanced cancers has shown that so-called “cold” tumors that are nearly devoid of immune cells—and therefore unresponsive to immunotherapy—can be turned “hot” with extremely low doses of radiation and the rational…

RESEARCH — The Right Program Could Turn Cancer Killers into Immune Cells
| | | | | | | | | | | | | | |

RESEARCH — The Right Program Could Turn Cancer Killers into Immune Cells

Newswise — Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different “program” that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer…

End of content

End of content